ArticlePLoS neglected tropical diseases2025
Cholera in Sub-Saharan Africa: Unveiling neglected drivers and pathways to elimination.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Molecular characterization ofIJID regions · 2026Article
- Sub-Saharan African Countries: what challenges for achieving universal access to health?Revista latino-americana de enfermagem · 2026Article
- The convergence of health system, climate, and social pathways in Malawi's 2022-2024 cholera outbreak - A qualitative assessment.PLoS neglected tropical diseases · 2026Article
- Cholera in Africa: Current trends, challenges, and control towards elimination strategies.PLoS neglected tropical diseases · 2026Review
- Clinical presentation and outcome of cholera in a regional hospital in Khartoum State, Sudan.Sudanese journal of paediatrics · 2026Article
- Addressing the Recurrent and Protracted Cholera Outbreaks in Africa: Challenges and the Way Forward.Nature communications · 2025Article
- A new era of political-technical synergy in Africa's cholera response.Journal of public health in Africa · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cholera is a virulent infectious disease caused by the Gram-negative, comma-shaped bacteria Vibrio cholerae, after ingesting contaminated food and/or water. If left untreated, it can kill within 5 days. Since mid-2021 the world has recorded a notable increase in the seventh cholera pandemic, with high case fatality rate especially in Sub-Saharan Africa. Oral cholera vaccines are established but not readily available on the market, or if they are, they are not pocket friendly for low-resource-income countries. Hence, with the advent of green factory biotechnology, plant-derived edible vaccines are such a promising approach to supplement conventional vaccine methods. Human travellers are often the major transmitters as they move from region to region. Poor sanitation and inadequate clean water supply are services not readily available in most Sub-Saharan African countries, coupled with insufficient surveillance services, lack of early detection facilities, and the public not having ample awareness concerning sanitation and hygiene. This article highlights the epidemiology of cholera in Africa and expounds on what drives the outbreaks of cholera in this region. The discussion provides an in-depth analysis of the factors leading to the forsaken cholera drivers, emphasizing economic factors, culture, and environmental influences, particularly within the Sub-Saharan African communities. It presents a strategic blueprint approach that includes public health awareness, community participation, government involvement, and exploring emerging research tools. By merging these proposals into a unified context, a collective and practical methodology would be established to tackle the impact of cholera epidemiology that has been sidelined in Sub-Saharan Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.